Biotech Turnaround Fund (BTF)
Europe, Noord-Holland, The Netherlands, Bloemendaal
Description
Biotech Turnaround Fund (BTF) B.V. is a cross-over, turnaround venture capital operating company, focusing on building a portfolio of six
Investor Profile
Biotech Turnaround Fund (BTF) has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series D, Series E rounds (top funding stages).
- Majority of deals are located in Canada, United States.
- Strong thematic focus on Biotechnology, Genetics, Life Science.
Stage Focus
- Series Unknown (43%)
- Series D (29%)
- Series E (14%)
- Series A (14%)
Country Focus
- Canada (71%)
- United States (29%)
Industry Focus
- Biotechnology
- Genetics
- Life Science
- Medical Device
- Pharmaceutical
- Biopharma
- Medical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
